New Treatment Strategies for Hepatitis B | Harry Janssen, MD, PhD

International Hepatitis Cure & Eradication Meeting 2015

New tools for testing and monitoring Hepatitis B and C | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)

International Hepatitis Cure & Eradication Meeting 2015

Baby Boomer Screening in the U.S: Delivering on the promise thus far? | John Ward, MD

International Hepatitis Cure & Eradication Meeting 2015

Point-of-care (POC) testing in Hepatitis B and C | Scott Bowden, PhD

International Hepatitis Cure & Eradication Meeting 2015

Session 1 Panel Discussion

International Hepatitis Cure & Eradication Meeting 2015

A hepatitis C Vaccine: How do we prove it works? | Kimberly Page

International Hepatitis Cure & Eradication Meeting 2015

Hepatitis C Vaccines: Are we making progress? | Christopher M. Walker, PhD

International Hepatitis Cure & Eradication Meeting 2015

Long acting (LA) drug delivery in TB treatment | Andrew Owen, BSS, MSC, PhD, FSB

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Lost in translation: learning from preclinical data | Gerry Davies

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Charles Peloquin, PharmD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

A new model for early clinical development of TB drugs and its application to Q203 and BTZ043 | Norbert Heinrich, MD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016

Russian HIV Clinical Series | Natalia Litvinova | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Debate: Can we eliminate HCV from Africa? | Mark Nelson, MD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Debate: Can we eliminate HCV from Africa? | Richard Njouom, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

The new epidemic of drug resistant HIV-1 | Gillian Hunt, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

ALERRT - The African coaLition for Epidemic Research, Response and Training | Peter Horby, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

PANDORA-ID-NET | Francine Ntoumi, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Rise and spread of multi-drug resistant malaria | Francine Ntoumi, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Innovation in surveillance / early warning systems | Mah-Sere Keita, MPH

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Genomics for tracing the cholera epidemic in Africa | Francois-Xavier Weill, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

The role of the human/animal interface in the zoonoses | Jean-Jacques Muyembe, MD, PhD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

Fast-tracking vaccines for epidemic diseases: An update from CEPI | Richard Hatchett, MD

International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018

HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018